IDEA Pharma is a proud partner of Candel Therapeutics
Through an integrated partnership with EVERSANA and CANDEL, we are helping to change patient lives by maximizing the potential of aglatimagene besadenovec to raise the standards […]
News
Building the In Vivo Future: What Lilly’s Kelonia Bet Really Signals
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but
Is AI at the helm of biopharma business development strategies?
Jacqueline Poot President – Strategic Consulting & Analytics BU IDEA Pharma As a moderator of this session at BIOEuropeSpring, my
Acceptance of Campfire Session at 39th ECNP Congress 2026 Highlighting Urgent Need to Rethink Development in CIAS
IDEA Pharma Announces Acceptance of Campfire Session at 39th ECNP Congress 2026 Highlighting Urgent Need to Rethink Development in CIAS
SAI MedPartners and IDEA Pharma launch first ever China Pharmaceutical Innovation and Invention Index
– First ever launch of China Index recognizes the increased strength of innovation in Chinese Pharma and Biotech and its
SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group
SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group December 3, 2025 Reading, PA SAI
2025 Collaborating for Novel Solutions (CNS) Summit: Annual Pharma Digital Innovation Index, cements leaders in the Biopharmaceutical innovation of digital solutions.
Tuesday, November 4th, 2025, Boston, MA – Today, the annual Pharmaceutical Digital Innovation Index, a partnership between IDEA Pharma, a
Introducing the China PIII: A New Benchmark for Pharmaceutical Innovation in China
Shanghai, China – June 10, 2025 – As China advances its national strategy to foster pharmaceutical innovation and drive high-quality
SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device
SAI MedPartners Acquires PharmaForce
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device